Actively Recruiting
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
Led by University of Illinois at Chicago · Updated on 2024-11-21
126
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
Sponsors
U
University of Illinois at Chicago
Lead Sponsor
M
Massachusetts General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if the device did not get opened and a pre-identified social support person or case manager when 2 or 7 consecutive days of nonadherence are detected, respectively. The investigators call our approach "A-Team" (Antiretroviral Therapy Electronic Adherence Monitoring). The aims of this application are to determine the acceptability and feasibility of real-time adherence monitoring in support persons and case managers of African American Men who have sex with Men and to test this approach for these men in a 6-month randomized controlled trial among 54 of these men living with HIV and measure ART adherence and viral suppression (the primary outcome).
CONDITIONS
Official Title
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- African American men who have sex with men (AAMSM) over 18 years old with self-reported HIV infection
- Own a working cell phone
- On antiretroviral therapy (ART) for at least 6 months
- Have a case manager willing to participate (for the clinical trial)
- Have suboptimal adherence indicated by detectable viral load in past 6 months, self-reported adherence below 90%, or healthcare provider referral due to adherence problems
- Social support persons must have a meaningful relationship with the participant, be over 18, own a working cell phone, and be willing to provide support
- Case managers must have worked with clients with HIV for at least 6 months and own a working cell phone
You will not qualify if you...
- Not meeting the inclusion criteria
- Not agreeing to informed consent regarding interactions with the research team, data collection, and medical record access
- Not consenting to provide viral load results from 12 months before and after study start to confirm eligibility and allow long-term follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
M
Mark Dworkin, MD
CONTACT
A
Anita Shaperd, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here